MILWAUKEE--(BUSINESS WIRE)--Physicians Realty Trust (NYSE:DOC) (the “Company”), a self-managed healthcare real estate company, announced today the pricing of a public offering of 20,000,000 common shares of beneficial interest at a public offering price per share of $20.40, for net proceeds of approximately $390.98 million after deducting the underwriting discount and commissions and estimated offering expenses payable by the Company. All of the common shares in the public offering are being offered by the Company and will trade on the NYSE under the ticker symbol “DOC.”
The Company has granted the underwriters a 30-day option to purchase up to an additional 3,000,000 common shares. The offering is expected to close on July 5, 2017, subject to customary closing conditions.
The Company will contribute the net proceeds of this offering to Physicians Realty L.P., a Delaware limited partnership (the “Operating Partnership”), in exchange for common units in the Operating Partnership. The Operating Partnership intends to use the net proceeds of the offering to repay a portion of the outstanding indebtedness under its revolving credit facility, to fund its pending acquisitions, and for general corporate purposes, including, without limitation, working capital and investment in real estate.
KeyBanc Capital Markets, BofA Merrill Lynch, BMO Capital Markets, and Morgan Stanley are serving as book-running managers for the offering.
The offering is being made pursuant to the Company’s automatic shelf registration statement filed with the Securities and Exchange Commission (the “Commission”), which became effective on February 24, 2017. Copies of the final prospectus supplement and accompanying prospectus may be obtained from the Commission's website at www.sec.gov or by contacting: KeyBanc Capital Markets, 127 Public Square, 4th Floor, Cleveland, Ohio 44114, Attn: Equity Syndicate, or by telephone at (800) 859-1783; BofA Merrill Lynch, NC1-004-03-43, 200 North College Street, 3rd Floor, Charlotte, NC, 28255-0001, Attn: Prospectus Department, or by email at email@example.com; BMO Capital Markets Corp., Attention: Syndicate Department, 3 Times Square, 25th Floor, New York, New York 10036 or by telephone at (800) 414-3627 or by email at firstname.lastname@example.org; or Morgan Stanley at 180 Varick Street, 2nd Floor - New York, NY 10014, Attn: Prospectus Department.
This press release is not an offer to sell, nor a solicitation of an offer to buy securities, nor shall there be any sale of these securities in any state or jurisdiction in which the offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
About Physicians Realty Trust
Physicians Realty Trust is a self-managed healthcare real estate company organized to acquire, selectively develop, own and manage healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Company invests in real estate that is integral to providing high quality healthcare. The Company conducts its business through an UPREIT structure in which its properties are owned by the Operating Partnership, directly or through limited partnerships, limited liability companies or other subsidiaries. The Company is the sole general partner of the Operating Partnership and, as of March 31, 2017, owned approximately 96.6% of the partnership interests in our Operating Partnership (“OP Units”).
Investors are encouraged to visit the Investor Relations portion of the Company’s website (www.docreit.com) for additional information, including annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, press releases, supplemental information packages and investor presentations.
This press release contains statements that are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “anticipate”, “believe”, “expect”, “estimate”, “plan”, “outlook”, and “project” and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements may include statements regarding the Company’s strategic and operational plans, the Company’s ability to generate internal and external growth, the future outlook, anticipated cash returns, cap rates or yields on properties, anticipated closing of property acquisitions, and ability to execute its business plan. While forward-looking statements reflect our good faith beliefs, they are not guarantees of future performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on information available at the time those statements are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward looking statements. These forward-looking statements are subject to various risks and uncertainties, not all of which are known to the Company and many of which are beyond the Company’s control, which could cause actual results to differ materially from such statements. These risks and uncertainties are described in greater detail in the Company’s filings with the Commission, including, without limitation, the Company’s annual and periodic reports and other documents filed with the Commission. Unless legally required, the Company disclaims any obligation to update any forward-looking statements after the date of this release, whether as a result of new information, future events or otherwise. For a description of factors that may cause the Company’s actual results or performance to differ from its forward-looking statements, please review the information under the heading “Risk Factors” included in each of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2016 filed by the Company with the Commission on February 24, 2017 and the Company's Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2017 filed by the Company with the Commission on May 5, 2017.